Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 80, Issue 2 , Pages 107-114 , February 2009

Effects of Bothrops asper snake venom on the expression of cyclooxygenases and production of prostaglandins by peritoneal leukocytes in vivo, and by isolated neutrophils and macrophages in vitro

  • Vanessa Moreira

      Affiliations

    • Laboratorio de Farmacologia, Instituto Butantan, Av. Vital Brasil, 1500, CEP 05503-900, Sao Paulo, SP, Brazil
    • ,
  • José María Gutiérrez

      Affiliations

    • Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
    • ,
  • Rafaela Bacci Amaral

      Affiliations

    • Laboratorio de Farmacologia, Instituto Butantan, Av. Vital Brasil, 1500, CEP 05503-900, Sao Paulo, SP, Brazil
    • ,
  • Stella Regina Zamunér

      Affiliations

    • Laboratorio de Farmacologia, Instituto Butantan, Av. Vital Brasil, 1500, CEP 05503-900, Sao Paulo, SP, Brazil
    • ,
  • Catarina de Fátima Pereira Teixeira

      Affiliations

    • Laboratorio de Farmacologia, Instituto Butantan, Av. Vital Brasil, 1500, CEP 05503-900, Sao Paulo, SP, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +551137267222; fax: +551137261505.

Received 21 February 2008 ,Revised 7 July 2008 ,Accepted 17 November 2008.

References 

  1. Gómez H, Dart RC. Clinical toxicology of snakebite in north America. In:  Meier J,  White J editor. Handbook of Clinical Toxicology of Animal Venoms and Poisons. Boca Raton: CRC Press; 1995;p. 619–644
  2. Gutiérrez JM. Clinical toxicology of snakebite in Central America. In:  Meier J,  White J editor. Handbook of Clinical Toxicology of Animal Venoms and Poisons. Boca Raton, FL: CRC Press; 1995;p. 667–668
  3. Fan WH, Cardoso JL. Clinical toxicology of snakebite in North America. In:  Meier J,  White J editor. Handbook of Clinical Toxicology of Animal Venoms and Poisons. Boca Raton, FL: CRC Press; 1995;p. 667–688
  4. Warrel DA. Clinical features of envenoming from snake bites. In:  Bon C,  Goyffon M editor. Envenoming and their Treatments. Lyon: Editions Foundation Marcel Mérieux; 1996;p. 63–76
  5. Rosenfeld G. Symptomatology, pathology and treatment of snake bites in South America. In:  Bucherl W,  Buckley E editor. Venomous Animals and Their Venoms Venomous Vertebrates. vol. II:New York: Academic Press; 1971;p. 345–384
  6. Teixeira CFP, Zamunér SR, Zuliani JP, Fernandes CM, Cruz-Hofling MA, Fernandes I, et al. Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Botrhops asper snake venom. Muscle Nerve. 2003;28:449–459
  7. Zamunér SR, Gutiérrez JM, Muscará MN, Teixeira SA, Teixeira CFP. Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo. Toxicon. 2001;39:1505–1513
  8. Zamunér SR, Zuliani JP, Fernandes CM, Gutiérrez JM, Teixeira CFP. Inflammation induced by Bothrops asper venom: release of proinflammatory cytokines and eicosanoids, and role of adhesion molecules in leukocyte infiltration. Toxicon. 2005;46:806–813
  9. Teixeira CFP, Cury Y, Oga S, Jancar S. Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF). Toxicon. 1994;32:419–426
  10. Chaves F, Barbosa M, Gutiérrez JM. Pharmacological study of edema induced by venom of the snake Bothrops asper (Terciopelo) in mice. Toxicon. 1995;33:31–39
  11. Chaves F, Teixeira CF, Gutiérrez JM. Role of TNF-alpha, IL-1 beta and IL-6 in the local tissue damage induced by Bothrops asper snake venom: an experimental assessment in mice. Toxicon. 2005;45:171–178
  12. Chacur M, Picolo G, Gutiérrez JM, Teixeira CFP, Cury Y. Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venom. Toxicon. 2001;39:1173–1181
  13. Smith W, Marnett L. Prostaglandin endoperoxide synthase: structure and catalysis. Biochem. Biophys. Acta. 1991;1083:1–17
  14. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol. 2002;23:144–150
  15. Narumiya S, Fitzgerald GA. Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 2001;108:25–30
  16. Rocca B, Fitzgerald GA. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2002;2:603–630
  17. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 1998;38:97–120
  18. Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. 1996;184:883–891
  19. Nakamura M, Ferreira SH. A peripheral sympathetic component in inflammatory hyperalgesia. Eur. J. Pharmacol. 1987;135:145–153
  20. Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 1991;104:765–767
  21. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 1992;107:660–664
  22. Ferreira SH, Lorenzetti BB, Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 1993;110:1227–1231
  23. Poole S, Lorenzetti BB, Cunha JM, Cunha FQ, Ferreira SH. Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br. J. Pharmacol. 1999;126:649–656
  24. Reddy ST, Herschman HR. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J. Biol. Chem. 1994;269:15473–15480
  25. Morham SG, Langenbach RR, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, et al. The eicosanoids and their biochemical mechanisms of action. Biochem. J. 1989;259:315–324
  26. Giles H, Leff P. The biology and pharmacology of PGD2. Prostaglandins. 1988;35:277–300
  27. Wright DH, Nantel F, Metters KM, Ford-Hutchinson AW. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. Eur. J. Pharmacol. 1999;377:101–115
  28. Kanaoka Y, Urade Y. Hematopoietic prostaglandin D synthase. Prostaglandins Leukot. Essent. Fatty Acids. 2003;69:163–167
  29. Hart PH. Regulation of the inflammatory response in asthma by mast cell products. Immunol. Cell Biol. 2001;79:149–153
  30. Nagoshi H, Uehara Y, Kanai F, Maeda S, Ogura T, Goto A, et al. Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circ. Res. 1998;82:204–209
  31. Murray JJ, Tonnel AB, Brash AR, Roberts II LJ, Gosset P, Workman R, et al. Release of prostaglandin D2 into human airways during acute antigen challenge. N. Engl. J. Med. 1986;315:800–804
  32. Barr RM, Koro O, Francis DM, Black AK, Numata T, Greaves MW. The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions. Br. J. Pharmacol. 1988;94:773–780
  33. Smith S, Deitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 2000;69:145–182
  34. Herschmann HR. Prostaglandin synthase 2. Biochim. Biophys. Acta. 1996;1299:125–140
  35. Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes?. J. Clin. Invest. 2001;107:1491–1495
  36. Ford-Hutchinson AW, Bray MA, Smith MJ. Lipoxygenase products and the polymorphonuclear leucocyte. Agents Actions. 1980;10:548–550
  37. Zurier RB. Prostaglandin release from human polymorphonuclear leukocytes. Adv. Prostaglandin Thromboxane Res. 1976;2:815–818
  38. Pradelles P, Grassi J, Mac Louf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal. Chem. 1985;57:1170–1173
  39. Olivo RA, Teixeira CFP, Wallace JL, Gutiérrez JM, Zamunér SR. Role of cyclooxygenases in oedema-forming activity of bothropic venoms. Toxicon. 2007;49:670–677
  40. Moreira V, Zamunér SR, Wallace JL, Teixeira CFP. Bothrops jararaca and Crotalus durissus terrificus venoms elicit distinct responses regarding to production of prostaglandins E2 and D2, and expression of cyclooxygenases. Toxicon. 2007;49:615–624
  41. Herschman HR. Function and regulation of prostaglandin synthase 2. Adv. Exp. Med. Biol. 1999;469:3–8
  42. Ito S, Narumiya S, Hayaishi O. Prostaglandin D2: a biochemical perspective. Prostaglandins Leukot. Essent. Fatty Acids. 1989;37:219–234
  43. James MJ, Penglis PS, Caughey GE, Demasi M, Clenland LG. Eicosanoids production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?. Inflamm. Res. 2001;50:249–253
  44. Giuliano F, Warner TD. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. J. Pharmacol. Exp. Ther. 2002;303:1001–1006
  45. Hartert TV, Dworski RT, Mellen BG, Oates JA, Murray JJ, Sheller JR. Prostaglandin E(2) decreases allergen stimulated release of prostaglandin D(2) in airways of subjects with asthma. Am. J. Respir. Crit. Care Med. 2000;162:637–640
  46. Barrios-Rodiles M, Chadee K. Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-γ in human macrophages. J. Immunol. 1998;161:2441–2448
  47. Diaz A, Chepenik KP, Korn JH, Reginato AM, Jimenez SA. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp. Cell Res. 1998;241:222–229
  48. Petricevich VL, Teixeira CFP, Tambourgi DV, Gutiérrez JM. Increments in cytokine and nitric oxide serum levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms. Toxicon. 2000;38:1253–1266
  49. James MJ, Penglis PS, Caughey GE, Demasi M, Cleland LG. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?. Inflamm. Res. 2001;50:249–253
  50. Murakami M, Kambe T, Shimbara S, Higashino K, Hanasaki K, Arita H, et al. Different functional aspects of the group II subfamily (Types IIA and V) and type X secretory phospholipase A2 in regulating arachidonic acid release and prostaglandin generation. Implications on cyclooxygenase-2 induction and phospholipids scramblase-mediated cellular membrane perturbation. J. Biol. Chem. 1999;274:31435–33144
  51. Murakami M, Matsumoto R, Austen KF, Arm JP. Prostaglandin endoperoxide synthase-1 and-2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. J. Biol. Chem. 1994;269:22269–22275
  52. Kuwata H, Nakatani Y, Murakami M, Kudo I. Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. 1998;273:1733–1740
  53. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular Biology. Annu. Rev. Biochem. 2000;69:145–182
  54. Murakami M, Nakatani Y, Kuwata H, Kudo I. Cellular components that functionally interact with signaling phsopholipase A2s. Biochim. Biophys. Acta. 2000;1488:159–166
  55. Gutiérrez JM, Lomonte B. Phospholipase A2 myotoxins from Bothrops snake venoms. Toxicon. 1995;33:1405–1424
  56. Wilborn J, DeWitt DL, Peters-Golden M. Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am. J. Physiol. 1995;268:L294–L301
  57. Gordon S. The macrophage. Bioessays. 1995;17:977–986
  58. Kay AB. Leucocytes in asthma. Immunol. Invest. 1988;17:679–705
  59. Maloney CG, Kutchera WA, Albertine KH, Mcintyre TM, Prescott SM, Zimmerman GA. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J. Immunol. 1998;160:1402–1410
  60. Crawford RM, Leiby DA, Green SJ, Nacy CA, Fortier AH, Meltzer MS. Macrophage activation: a riddle of immunological resistance. Immunol. Ser. 1994;60:29–46
  61. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. The neutrophil as a cellular source of chemokines. Immunol. Rev. 2000;177:195–203

PII: S0952-3278(08)00184-1

doi: 10.1016/j.plefa.2008.11.009

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 80, Issue 2 , Pages 107-114 , February 2009

Article Tools

* Image Usage & Resolution